Healthier World with Quest Diagnostics

In this episode of Healthier World designed to give you instant insights, we introduce the Cleveland HeartLab and its role as a Center of Excellence for cardiometabolic, endocrine, and wellness testing at Quest Diagnostics. In this episode, Dr. Maeson Latsko hosts a segment featuring various leaders from Cleveland HeartLab and Quest Diagnostics, including Marc Penn, MD, PhD, Mouris Saghir, PhD, Ti...

Obesity affects over 40% of adults in the United States. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for the treatment of type 2 diabetes, have shown significant efficacy in promoting weight loss and are increasingly prescribed for obesity management. In today’s episode, Millicent Kee, MSN, FNP-BC, Clinical and Education Specialist, and Patty Bianc...

In this special episode of Healthier World designed to give you Instant Insights, we review a panel that takes a deeper look at cardiovascular, renal, hepatic, endocrine, and metabolic health—a network of systems that work together to determine a person’s long-term health. Today we will break down what this panel includes and how it can help prevent the onset of chronic disease years before sympto...

In this special episode of Healthier World designed to give you Instant Insights, we explore a vascular-specific inflammatory marker that can indicate risk for cardiometabolic disease and all-cause mortality—myeloperoxidase. In this episode, we break down the biology and function of MPO, its contribution to vascular inflammation, and its potential as a biomarker of vulnerable soft plaque in the ar...

Inflammation plays a critical role in cardiometabolic diseases, but traditional risk markers like LDL-C and hs-CRP don’t tell the whole story. Myeloperoxidase (MPO), an enzyme linked to oxidative stress and immune activation, may offer a deeper look into hidden cardiovascular and metabolic risk. In this episode, Dr Marc Penn unpacks the new research examining the association between MPO and the ri...

In this special episode of Healthier World designed to give you Instant Insights, we dive into advanced lipid testing—going beyond a standard lipid panel. Today, we will explore two powerful tools used to look at lipoprotein fractionation: ion mobility and nuclear magnetic resonance (NMR). We will look at how these tests work and how they can uncover hidden risk for cardiovascular disease. This ep...

In this special episode of Healthier World designed to give you Instant Insights, we take a look at primary aldosteronism (PA)- an often underdiagnosed, yet prevalent cause of hypertension. In this episode, we challenge traditional screening methods and introduce a streamlined diagnostic approach. By recognizing the signs of Primary Aldosteronism earlier, providers can improve patient outcomes and...

Understanding the diagnosis and treatment in primary aldosteronism (PA) often feels elusive to most providers. PA is marked by the elevation of aldosterone and the suppression of renin leading to a disproportionately higher risk of cardiovascular, kidney, and metabolic disease compared to those patients with essential hypertension, yet this condition is often undiagnosed. This episode will discuss...

Cardiovascular disease (CVD) is the leading cause of death in men and women, yet 45% of women don’t know it’s their leading cause of death. A staggering 71% of women never discuss heart health with their physicians. This episode will explore this gender disparity and elucidate why women carry unique risk for cardiovascular and metabolic diseases. Today’s episode is with clinical educators Trisha W...

Approximately 120 million people in the US have hypertension, which is about half of the adult population. Identifying the mechanisms that cause hypertension is crucial for the proper treatment of patients, yet 9 out of 10 patients do not know the origin of their hypertension. New research reveals that up to 30% of patients suffer from hypertension due to primary aldosteronism (PA). With less than...

More than 1 in 7 US adults are estimated to have chronic kidney disease, or CKD, and as many as 9 in 10 don’t know they have it.  Damage to your kidneys cannot be reversed, but if found early, there are ways to prevent its progression such as following a healthy eating plan and being physically active.  Today’s episode is with Patty Bianchi, Registered Dietitian Nutritionist and Certified Diabetes...

As many as 45% of Americans have a chronic disease. Shared cardiometabolic risk factors contribute to related conditions, such as cardiovascular disease, poor glycemic control, chronic kidney disease, fatty liver disease, and common endocrine disorders. As evidence demonstrating the interrelationships between chronic cardiometabolic diseases continues to expand, establishing a personalized approac...

1in 7 US adults are estimated to have chronic kidney disease, or CKD. Because early stages of the disease are often clinically silent, 90% of individuals with CKD don’t know they have it. This podcast highlights the importance of early CKD detection and the need for proper screening, especially in individuals with hypertension and diabetes. The Kidney Profile aligns with guidelines and includes th...

Increased rates of obesity and type 2 diabetes are increasing rates of cardiometabolic conditions. Identifying and intervening in early stages of metabolic dysfunction is crucial in order to delay and prevent disease progression. The Metabolic Risk Panel is a comprehensive test that helps identify individuals at risk for metabolic dysfunction, insulin resistance, and cardiovascular disease. The pa...

Identifying insulin resistance offers significant—and often untapped—clinical value and can help healthcare providers and their patients take action with diet and lifestyle choices to avoid or change the progression to prediabetes and diabetes. Today’s episode features Patty Bianchi, Registered Dietitian Nutritionist and Certified Diabetes Care and Education Specialist and Trisha Winchester, PhD,...

Metabolic dysfunction is a common root cause of many cardiometabolic conditions that burden the healthcare system. This episode will address insulin resistance, a syndrome that underlies metabolic dysfunction, and how tools can catch risk early, allowing actions that may prevent and reverse the onset of chronic illness. Today’s episode is with Quest Diagnostics experts Kenneth French, Senior Clini...

Despite advances in understanding the pathogenesis and prevention of atherosclerotic cardiovascular disease, coronary heart disease remains the leading cause of death in the United States. Apolipoprotein B (ApoB)—containing lipoproteins more closely identifies atherosclerosis and correlates to atherogenic particles in circulation. This episode will: Review the current state of cardiovascular risk...

Despite advances in understanding the pathogenesis and prevention of atherosclerotic cardiovascular disease, coronary heart disease remains the leading cause of death in the United States. Lipoprotein (a), or Lp(a), is a particularly atherogenic type of lipoprotein, where excess levels significantly influence cardiovascular risk.   This episode will: Review the significant cardiovascular implicati...

Hypogonadism is a common condition in the male population, impacting approximately 35% of men over 45 years of age. Today’s episode is with Quest Diagnostics experts Dr Sanjay Dixit, MD, medical director, and Maeson Latsko, PhD, clinical specialist. This episode will: Review the clinical and biochemical changes seen in male patients with hypogonadism (1:20) Discuss the guideline-recommended method...

An estimated 20 million Americans have some form of thyroid disease, and up to 60% of them are unaware of their condition. Today’s episode is with Quest Diagnostics experts Dr Sanjay Dixit, MD, medical director, and Sarah Walsh, PA-C, CLS, clinical specialist.    This episode will: Identify common signs and symptoms of thyroid dysfunction Identify lab recommendations to support the diagnosis of hy...

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine diagnoses for reproductive-aged women and carries lifelong cardiometabolic risk. Today’s episode is with Quest Diagnostics experts Dr Sanjay Dixit, MD, medical director, and Sarah Walsh, PA-C, CLS, clinical specialist. This episode will: Review the diagnostic criteria for PCOS (2:00) Identify lab recommendations to support the di...